Navigation Links
Professor Sir Martin Evans wins Nobel Prize for Medicine

Professor Sir Martin Evans, Professor of Mammalian Genetics at the School of Biosciences, Cardiff University, has won the 2007 Nobel Prize for Medicine.

The Nobel Assembly at the Karolinska Institute, Sweden, announced this morning that Professor Sir Martin was one of three winners for a series of ground-breaking discoveries concerning embryonic stem cells and DNA recombination in mammals.

Professor Sir Martin was the first scientist to identify embryonic stem cells, which can be adapted for a wide variety of medical purposes. His discoveries are now being applied in virtually all areas of biomedicine from basic research to the development of new therapies. The work has already proved of great benefit in the study of cystic fibrosis.

He has been congratulated by the British Prime Minister, Gordon Brown, who said: This is a proud day for Sir Martin, for Cardiff University and for the country.

The Nobel Assembly said of Professor Sir Martins work: Its impact on the understanding of gene function and its benefits to mankind will continue to increase over many years to come.

Professor Sir Martin shares the 755,000 prize with Professor Mario Capecchi of the University of Utah and Professor Oliver Smithies of the University of North Carolina.

He said: Im very pleased that British science is being honoured in this way. It is a pleasure and it is the highest honour in science. It is a boyhood dream come true.

In a congratulatory message, Gordon Brown said: I want to congratulate Professor Sir Martin Evans on this marvellous achievement. This is a proud day for Sir Martin, for Cardiff University and for the country.

Last week, Lord Sainsbury, the Chancellor and I launched a new strategy to make Britain a world leader in science and technology. It is my hope that our budding young scientists will follow the lead of Sir Martin Evans and that the UK can produce many more Nobel Prize winners in the years ahead.

The Vice-Chancellor of Cardiff University, Dr David Grant, said: Cardiff University is delighted to join the world-wide congratulations for Sir Martin Evans. The Nobel Prize is tribute not just to the academic brilliance of Sir Martins discoveries, once thought by many to be impossible, but also to the wide-ranging benefits of his research.

As the Nobel Assembly correctly points out, the break-throughs by Sir Martin and his fellow Nobel laureates have generated an explosion of international research activity applying their techniques. Sir Martin himself has developed models for diseases such as human breast cancer, just one of the diseases where our understanding has been revolutionised, offering hope to millions of sufferers around the world.

Professor John Harwood, Head of the School of Biosciences, said: This is fantastic news and clearly is very well deserved. Martins research into stem cells and gene therapy is very important and offers also sorts of promise to medicine.

This is also marvellous news for Cardiff University and Wales. Cardiff improves year on year and this is another accolade for the University. In science it doesn't come any higher than the Nobel Prize.

Professor Sir Martin has been a key figure in establishing Cardiff University as a world-leading centre for biomedical research. The University was listed in the worlds top 100, and the top ten in the UK, for biomedicine in last years Times Higher Educational Supplement World University Rankings.


Contact: Stephen Rouse
Cardiff University

Related biology news :

1. Great White shark evolution debate involves WSU Lake Campus geology professor
2. K-State professors discover enzyme responsible for creation of a beetles hard shell
3. Pitt professors theory of evolution gets boost from cell research
4. DNA conclusive yet still controversial, Carnegie Mellon professor says
5. Professors to develop hand-held pathogen testing device
6. LSU professor discovers new species
7. Outsmarting the smartie bug
8. Papers of DNA Pioneer and Nobel Laureate Francis Crick Added to National Library of Medicine’s Profiles in Science Web Site
9. Nobelist discovers antidepressant protein in mouse brain
10. Comments, experts and background on the 2006 Nobel Prize in chemistry
11. Nobel Laureate finds elegant explanation for DNA transcribing enzymes high fidelity
Post Your Comments:
(Date:6/15/2016)... York , June 15, 2016 ... new market report titled "Gesture Recognition Market by Application ... Forecast, 2016 - 2024". According to the report, the  ... 11.60 billion in 2015 and is estimated to ... USD 48.56 billion by 2024.  Increasing ...
(Date:6/9/2016)... 2016 Paris Police Prefecture ... security solution to ensure the safety of people and operations ... the major tournament Teleste, an international technology group ... announced today that its video security solution will be utilised ... up public safety across the country. The system roll-out is ...
(Date:6/3/2016)... Das DOTM (Department ... hat ein 44 Millionen $-Projekt ... einschließlich Personalisierung, Registrierung und IT-Infrastruktur, an Decatur ... Implementierung von Identitätsmanagementlösungen. Zahlreiche renommierte internationale Anbieter ... aber Decatur wurde als konformste und innovativste ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... ... June 27, 2016 , ... Newly created 4Sight Medical ... to the healthcare market. The company's primary focus is on new product introductions, ... strategies that are necessary to help companies efficiently bring their products to market. ...
(Date:6/24/2016)... Epic Sciences unveiled a liquid biopsy ... PARP inhibitors by targeting homologous recombination deficiency (HRD) ... test has already been incorporated into numerous clinical ... Over 230 clinical trials are investigating ... PARP, ATM, ATR, DNA-PK and WEE-1. Drugs targeting ...
(Date:6/23/2016)... 23, 2016   Boston Biomedical , an ... designed to target cancer stemness pathways, announced that ... Orphan Drug Designation from the U.S. Food and ... cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin is ... inhibit cancer stemness pathways by targeting STAT3, and ...
(Date:6/23/2016)... 23, 2016  The Prostate Cancer Foundation (PCF) is pleased to ... faster cures for prostate cancer. Members of the Class of 2016 were selected ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
Breaking Biology Technology: